FIELD-LAB is a drug discovery facility that will help you to speed up the development and market launch of new nuclear drugs for cancer treatment. Through supply of small batches of radio chemicals and radio pharmaceuticals, we meet the need of Bio Pharma scientists and start-up ventures for research materials. This will drive both their ambitions to develop a new drug.
FIELD-LAB has a unique and complete nuclear infrastructure.
Read more about Nuclear Infrastructure
Currently, research is done on the production and development of various isotopes:
Learn more about FIELD-LAB and its importance. Discover our global network for pre-clinical and clinical research: research that is part of the development of every new medical product.
FIELD-LAB is created for and together with partners from different backgrounds. Some of the finest Dutch UMC’s have committed themselves to be part of this initiative. They believe in the beneficial results that will be brought to the Nuclear Medicine society. In addition, the partnerships that arise from FIELD-LAB form a portal to a fast growing network, which results in an open innovation environment.
FIELD-LAB is the incubator for new nuclear medicines. Together with partners Field-LAB Developt new nuclear medicines for personalised treatment of cancer patients.
The official launch of FIELD-LAB took place on February 6, 2019 in Petten. A unique collaboration to benefit a wide range of patients.